Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Mar 23, 2020 $67.13 +4.08% $64.50 X 95.92% 1
Mar 23, 2020 Bearish $64.50 X 1
Kalpa Fernando Kalpa Fernando @KalpaFernando.140483
Feb 18, 2020 Bearish $93.61 X 1
JS JS Pro
Feb 18, 2020 $92.49 -1.20% $93.61 X 98.80% 2
Chaser Chaser Pro
Dec 26, 2019 $91.13 +1.45% $89.83 X 98.55% 1
Alan Alan Pro @Alan.115878
Nov 26, 2019 $88.63 +1.04% $87.72 X 98.96% 1
Oct 7, 2019 $74.66 +0.44% $74.33 X 99.56% 5
Jorge Jorge @Jorge.115344
Jul 10, 2019 $85.51 +19.34% $71.65 X 80.66% 0
Chaser Chaser Pro
Jun 28, 2019 $68.10 -6.35% $72.72 X 93.65% 0
Jun 26, 2019 $63.53 -6.57% $68.00 X 93.43% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE